Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid-Reference-Cited by-同舟云学术

Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid

Published:2014-12-10 Issue:12 Volume:136 Page:2967-2972
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Jelaković Bojan¹,Castells Xavier²,Tomić Karla³,Ardin Maude²,Karanović Sandra¹,Zavadil Jiri²

Affiliation:

1. Department for Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Center; School of Medicine, University of Zagreb; Zagreb Croatia

2. Molecular Mechanisms and Biomarkers Group; International Agency for Research on Cancer; Lyon France

3. Department of Pathology; Dr Josip Benčević General Hospital; Slavonski Brod Croatia

Funder

Croatian Science Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Aristolochic acid nephropathy: a worldwide problem;Debelle;Kidney Int,2008

2. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review;Gokmen;Ann Intern Med,2013

3. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease;Grollman;Environ Mol Mutagen,2013

4. Aristolochic acid and the etiology of endemic (Balkan) nephropathy;Grollman;Proc Natl Acad Sci USA,2007

5. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid;Jelakovic;Kidney Int,2012

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-scale mutational signature analysis in archived fixed tissues;Mutation Research - Reviews in Mutation Research;2024-07

2. Structural and mechanistic insights into the transport of aristolochic acids and their active metabolites by human serum albumin;Journal of Biological Chemistry;2024-07

3. Mutational signature and prognosis in adenocarcinoma of the bladder;The Journal of Pathology;2024-01-05

4. A new era of mutation rate analyses: Concepts and methods;Zoological Research;2024

5. Association between hepatic angiosarcoma and end‐stage renal disease: nationwide population‐based evidence and enriched mutational signature of aristolochic acid exposure;The Journal of Pathology;2023-04-11